Lung cancer screening with low-dose spiral computed tomography: Evidence from a pooled analysis of two Italian randomized trials

European Journal of Cancer Prevention

Volumn 26, Issue 4, 2017, Pages 324-329

  Infante, Maurizio ^a   Sestini, Stefano ^b   Galeone, Carlotta ^b   Marchianò, Alfonso ^b   Lutman, Fabio R ^c   Angeli, Enzo ^d   Calareso, Giuseppina ^b   Pelosi, Giuseppe ^b   Sozzi, Gabriella ^b   Silva, Mario ^e   Sverzellati, Nicola ^e   Cavuto, Silvio ^f   La Vecchia, Carlo ^b   Santoro, Armando ^c   Alloisio, Marco ^c   Pastorino, Ugo ^b  

^a BORGO TRENTO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d Humanitas Gavazzeni Hospital   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

lung cancer; meta analysis; mortality; screening

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; LOW ENERGY RADIATION; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; ADENOCARCINOMA; AGED; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ITALY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84969915584     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000264     Document Type: Article

References (37)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395-409
2. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. (2012). Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307: 2418-2429
3. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK (2011). UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66: 308-313
4. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. (2015). Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization. J Thorac Oncol 10: 890-896
5. Bray FI, Weiderpass E (2010). Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer 126: 1454-1466
6. Cox DR (1972). Regression models and life-tables. J R Stat Soc B 34: 187-220
7. Crino L, Weder W, van Meerbeeck J, Felip E (2010). Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 (Suppl 5): v103-v115
8. Cui JW, Li W, Han FJ, Liu YD (2015). Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals. Transl Lung Cancer Res 4: 275-286
9. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. (2014). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 15: 23-34
10. Field JK, van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, et al. (2013). European randomized lung cancer screening trials: post NLST. J Surg Oncol 108: 280-286
11. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. (2013). Screening for lung cancer with low-dose computed tomography: a systematic review to update the US preventive services task force recommendation. Ann Intern Med 159: 411-420
12. Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, et al. (2008). International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 17: 3081-3089
13. Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, et al. (2008). Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 59: 355-363
14. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. (2009). A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 180: 445-453
15. Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, et al. (2015). Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 191: 1166-1175
16. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. (2009). Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64: 34-40
17. Malvezzi M, Bosetti C, Rosso T, Bertuccio P, Chatenoud L, Levi F, et al. (2013). Lung cancer mortality in European men: trends and predictions. Lung Cancer 80: 138-145
18. Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, et al. (2015). European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?. Ann Oncol 26: 779-786
19. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, et al. (2013). Screening for lung cancer. Cochrane Database Syst Rev 6: CD001991
20. Mathers CD, Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442
21. McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. (2014). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383: 2127-2135
22. Meza R, Meernik C, Jeon J, Cote ML (2015). Lung cancer incidence trends by gender, race and histology in the United States 1973-2010. PLoS One 10: e0121323
23. Morere JF, Viguier J, Touboul C, Pivot X, Blay JY, Coscas Y, et al. (2015). Lung cancer risks, beliefs and healthcare access among the underprivileged. Eur J Cancer Prev 24 (Suppl): S82-S86
24. Pastorino U (2010). Lung cancer screening. Br J Cancer 102: 1681-1686
25. Pastorino U (2013). Current status of lung cancer screening. Thorac Surg Clin 23: 129-140
26. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, et al. (2012). Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21: 308-315
27. Pastorino U, Boffi R, Marchiano A, Sestini S, Munarini E, Calareso G, et al. (2016). Stopping smoking reduces mortality in low-dose computed tomography screening participants. J Thorac Oncol (In press
28. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al. (2012). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379: 432-444
29. Pozzi P, Munarini E, Bravi F, Rossi M, La Vecchia C, Boffi R, et al. (2015). A combined smoking cessation intervention within a lung cancer screening trial: a pilot observational study. Tumori 101: 306-311
30. Rosso T, Bertuccio P, La Vecchia C, Negri E, Malvezzi M (2015). Cancer mortality trend analysis in Italy, 1980-2010, and predictions for 2015. Tumori 101: 664-675
31. Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA Cancer J Clin 64: 9-29
32. Tammemagi MC, Lam S (2014). Screening for lung cancer using low dose computed tomography. BMJ 348: g2253
33. van den Bergh KA, Essink-Bot ML, Bunge EM, Scholten ET, Prokop M, van Iersel CA, et al. (2008). Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 113: 396-404
34. Vansteenkiste J, De Ruysscher D, Eberhardt WE, Lim E, Senan S, Felip E, et al. (2013). Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 (Suppl 6): vi89-vi98
35. Wille MM, Dirksen A, Ashraf H, Saghir Z, Bach KS, Brodersen J, et al. (2015). Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 193: 542-551
36. Winn DM, Lee YC, Hashibe M, Boffetta P (2015). The INHANCE consortium: toward a better understanding of the causes and mechanisms of head and neck cancer. Oral Dis 21: 685-693
37. Xie J, Liu C (2005). Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med 24: 3089-3110